Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:53:21 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



E:CYBN - CYBIN INC. - https://www.cybin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYBN - E  0.111.30·11.551.011.35-0.25-2.213.014216711.83  11.83  11.1019.46  6.9516:00:00Jul 1715 min
NEO exchange - E0.111.30·11.551.011.35-0.25-2.28.1907511.83  11.83  11.1019.46  6.9516:00:0015 min
Omega - O 11.31-0.29-2.50.44411.42  11.49  11.3115:40:0615 min
Chi-X - X 11.41-0.19-1.61.1121111.25  11.50  11.2515:50:0215 min
CX2 - H 11.31-0.29-2.50.89711.30  11.49  11.3015:40:0115 min
CXD - D 11.59-0.01-0.10.662011.59  11.59  11.5910:01:5315 min
TriAct - M 11.601.51545    15 min
Lynx - Y 11.21-0.39-3.40.56511.50  11.65  11.2114:43:0415 min

Recent Trades - Last 10 of 167
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00E11.35-0.250301 NEO Buy301 NEO BuyZ
15:59:27E11.35-0.2510084 ITG8479 CIBCK
15:58:51M11.43-0.17180 National Bank80 National BankE
15:57:43E11.40-0.2010084 ITG8479 CIBCK
15:50:16E11.50-0.1010084 ITG8479 CIBCK
15:50:16E11.50-0.101014 Virtu ITG19 DesjardinsE
15:50:02X11.41-0.1910079 CIBC1 AnonymousK
15:41:03M11.35-0.251880 National Bank7 TD SecE
15:40:06O11.31-0.291001 Anonymous1 AnonymousK
15:40:01H11.31-0.2910079 CIBC80 National BankK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-17 16:51C:CYBN11.60News ReleaseCybin gets U.K. OK for phase 3 Embrace depression trial
2025-07-01 09:50C:CYBN11.40News ReleaseGlobal Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
2025-06-30 22:03C:CYBN11.40News ReleaseCybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights
2025-06-30 21:54C:CYBN11.40SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-30 21:54C:CYBN11.40SEDAR MD & ASEDAR MD & A
2025-06-30 21:49C:CYBN11.40SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-30 21:27C:CYBN11.40News ReleaseCybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
2025-06-13 16:51C:CYBN11.20News ReleaseCybin talks partnerships, regulatory signals
2025-06-11 07:30C:CYBN12.20News ReleaseCybin to Participate in the 2025 Psychedelic Science Conference
2025-06-03 17:02C:CYBN11.25News ReleaseCybin receives U.S. patent for CYB004 DMT program
2025-05-20 12:33C:CYBN11.80News ReleaseCybin hears FDA pushing for psychedelic therapeutics
2025-05-15 16:49C:CYBN11.80News ReleaseCybin hires Thermo Fisher for phase 3 supply of CYB003
2025-05-14 07:30C:CYBN11.80News ReleaseCybin to Participate in the Alliance Global Partners Healthcare Company Showcase
2025-05-08 17:29C:CYBNNews ReleaseCybin receives U.S. patent for its CYB003 program
2025-05-01 07:30C:CYBN11.80News ReleaseCybin to Participate at the 28th Annual Milken Institute Global Conference
2025-04-23 07:30C:CYBN11.80News ReleaseCybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
2025-04-21 17:01C:CYBN11.80News ReleaseCybin forms partnership with Osmind
2025-02-10 21:48C:CYBN13.25News ReleaseCybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
2025-02-10 20:55C:CYBN13.25SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-10 20:49C:CYBN13.25SEDAR Interim Financial StatementsSEDAR Interim Financial Statements